We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants
SGYPW

Delisted

SGYPW was delisted on the 6th of December, 2016.

Back to rankings

3 hedge funds and large institutions have $725K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% less funds holding

Funds holding: 5 → 3 (-2)

54% less capital invested

Capital invested by funds: $1.57M → $725K (-$843K)

63% less call options, than puts

Call options by funds: $30K | Put options by funds: $80K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
$30K
Puts
$80K
Net Calls
-$50K
Net Calls Change
-$50K

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$2.1K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$751K
2
U
UBS
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$713K – – –
CAL
2
Capital Advisors Ltd
Ohio
$10K – – –
TRCT
3
Tower Research Capital (TRC)
New York
$2K +$2.1K +960 +1,200%
SM
4
Sabby Management
Florida
– -$751K -349,217 Closed
U
5
UBS
Switzerland
– -$1K -615 Closed

SGYPW Hedge Fund Activity: Q1 2014 in Review

3 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q1 2014, worth a combined $725K — down 54% from $1.57M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SGYPW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $2.1K. The largest seller was Sabby Management, exiting entirely with an estimated $751K sold.

  • 3 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q1 2014, down from 5 in Q4 2013.
  • Funds reported $725K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q1 2014, down 54% quarter-over-quarter.
  • 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q1 2014 and 2 closed out, a net change of -2 holders.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q1 2014 was Tower Research Capital (TRC), an estimated $2.1K added.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q1 2014 was Sabby Management, an estimated $751K sold.

Based on aggregated 13F filings for Q1 2014.